OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Net Current Assets History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹-55 Cr | ₹-9.59 Cr | ₹-7.89 Cr | ₹1.50 Cr | ₹-1.55 Cr |
What is the latest Net Current Assets ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹-55 Cr |
| Mar2024 | ₹-9.59 Cr |
| Mar2023 | ₹-7.89 Cr |
| Mar2022 | ₹1.50 Cr |
| Mar2021 | ₹-1.55 Cr |
How is Net Current Assets of OXYGENTA PHARMACEUTICAL Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹-55 Cr | Negative | |
| Mar2024 | ₹-9.59 Cr | Negative | |
| Mar2023 | ₹-7.89 Cr | Negative | |
| Mar2022 | ₹1.50 Cr | Positive | |
| Mar2021 | ₹-1.55 Cr | - | |
Compare Net Current Assets of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹199.8 Cr | -1.8% | -13.9% | -39.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,086.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,616.0 Cr | -1.9% | -1.6% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,361.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹120,713.0 Cr | -1.2% | -2% | 2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,881.0 Cr | -1.2% | 1.5% | -6.1% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -1.8% |
-13.9% |
-39.8% |
| SENSEX | -0.3% |
-1.1% |
7.8% |
You may also like the below Video Courses